Huyen T. Nguyen

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Modeling Favipiravir Antiviral Efficacy Against Emerging Viruses: From Animal Studies to Clinical Trials.

Modeling Favipiravir Antiviral Efficacy Against Emerging Viruses: From Animal Studies to Clinical Trials.

Journal: CPT: pharmacometrics & systems pharmacology

Published: September 18, 2019

Erratum for Madelain et al., "Favipiravir Pharmacokinetics in Nonhuman Primates and Insights for Future Efficacy Studies of Hemorrhagic Fever Viruses".

Erratum for Madelain et al., "Favipiravir Pharmacokinetics in Nonhuman Primates and Insights for Future Efficacy Studies of Hemorrhagic Fever Viruses".

Journal: Antimicrobial agents and chemotherapy

Published: December 23, 2017

Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques.

Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques.

Journal: PLoS medicine

Published: August 22, 2017

Determining Ribavirin's mechanism of action against Lassa virus infection.

Determining Ribavirin's mechanism of action against Lassa virus infection.

Journal: Scientific reports

Published: March 28, 2017

The paradox of highly effective sofosbuvir-based combination therapy despite slow viral decline: can we still rely on viral kinetics?

The paradox of highly effective sofosbuvir-based combination therapy despite slow viral decline: can we still rely on viral kinetics?

Journal: Scientific reports

Published: March 27, 2017

Individual Bayesian Information Matrix for Predicting Estimation Error and Shrinkage of Individual Parameters Accounting for Data Below the Limit of Quantification.

Individual Bayesian Information Matrix for Predicting Estimation Error and Shrinkage of Individual Parameters Accounting for Data Below the Limit of Quantification.

Journal: Pharmaceutical research

Published: March 24, 2017

Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens.

Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens.

Journal: PloS one

Published: January 31, 2017

Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted.

Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted.

Journal: PLoS neglected tropical diseases

Published: September 26, 2016

Favipiravir Pharmacokinetics in Nonhuman Primates and Insights for Future Efficacy Studies of Hemorrhagic Fever Viruses.

Favipiravir Pharmacokinetics in Nonhuman Primates and Insights for Future Efficacy Studies of Hemorrhagic Fever Viruses.

Journal: Antimicrobial agents and chemotherapy

Published: June 19, 2016

Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling study.

Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling study.

Journal: The Lancet. Global health

Published: March 10, 2016

Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials.

Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials.

Journal: Clinical pharmacokinetics

Published: January 23, 2016

Ebola virus dynamics in mice treated with favipiravir.

Ebola virus dynamics in mice treated with favipiravir.

Journal: Antiviral research

Published: April 21, 2015

Showing 1-12 of 14

Last Updated: 09/26/2026